Answers are grounded in this paper and cite their sources.
Randomized trial demonstrates sustained IGF-1 increase in healthy men using SCO-240, indicating potential for treating GH deficiency.
Objective Somatostatin receptor 5 (SSTR5) negatively regulates growth hormone (GH) secretion in the human pituitary. Current therapy for GH deficiency (GHD) relies on exogenous recombinant GH injections, posing a significant treatment burden. SCO-240 is a novel, oral selective SSTR5 antagonist designed to stimulate the GH/insulin-like growth factor 1 (IGF-1) axis by “releasing the brake” on endogenous GH secretion. We evaluated whether sustained SSTR5 antagonism could induce a durable IGF-1 response while maintaining endocrine selectivity and metabolic neutrality. Design and Methods In this randomized, double-blind, placebo-controlled Phase 1 study, 32 healthy Japanese men received once-daily oral SCO-240 (3, 10, 20, or 80 mg) or placebo for 7 days. Safety, pharmacokinetics, the GH–IGF-1 axis, metabolic parameters, and anterior pituitary hormones were assessed. Results SCO-240 was safe and well-tolerated; all treatment-emergent adverse events were mild and resolved spontaneously. Steady-state plasma concentrations of SCO-240 were achieved by Day 2. SCO-240 induced a robust, sustained increase in serum IGF-1 across all dose levels, which remained elevated above placebo from Day 2 through Day 8. This response was driven by enhanced GH secretion, characterized by persistent basal tone and enhanced pulsatility. Notably, SCO-240 exhibited a metabolically neutral profile, with no alterations in other pituitary axes, fasting glucose, or fasting/post-prandial insulin levels. Conclusions Multiple oral doses of SCO-240 elicited selective, sustained, and physiologically regulated activation of the GH–IGF-1 axis without detrimental metabolic effects. These findings highlight SSTR5 as a druggable target and support SCO-240 as a potential first-in-class oral therapy for some forms of GHD.
No takes yet. Share an insight, caveat, or question.
Nishizaki et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: